Nature:新的一年生命科学领域会带来哪些惊喜

2016-12-26 MEI bio360

1 内部的世界预期更多的研究将会将重点放在人类微生物组 - 病毒,细菌和其他微生物在体内的收集,以及他们的基因如何影响健康 。 研究人员正在研究微生物组对脑发育和癌症的影响。 来自美国人类微生物群落项目的第二阶段的成果也可能即将到来,该项目着重于人类微生物群与早产和炎症性肠病和2型糖尿病的发病的联系。病毒是我们微生物组的一部分。Jezper/Alamy2 遗传学争议美国法院很可能裁决加州大学伯克利

1 内部的世界

预期更多的研究将会将重点放在人类微生物组 - 病毒,细菌和其他微生物在体内的收集,以及他们的基因如何影响健康 。 研究人员正在研究微生物组对脑发育和癌症的影响。 来自美国人类微生物群落项目的第二阶段的成果也可能即将到来,该项目着重于人类微生物群与早产和炎症性肠病和2型糖尿病的发病的联系。

病毒是我们微生物组的一部分。Jezper/Alamy

2 遗传学争议

美国法院很可能裁决加州大学伯克利分校和马萨诸塞州剑桥的Broad学院之间的CRISPR-Cas9专利纠纷。 最终确定发明基因编辑技术的研究所将可以收获数十亿美元的专利许可相关利益。 NgAgo,一个难以复制的基因编辑系统, 可以在后续研究的基础上决定其是沉是或浮 。 在英国,诊所现在可以申请许可证使用混合来自三个人的DNA的有争议的辅助再生技术。 该方案旨在防止儿童遗传通过母亲的线粒体(细胞的能量产生结构)传播的疾病。

3 T细胞的反击

一种史无前例的复杂癌症免疫治疗,称为CAR-T,看起来已经准备好了要打入市场。 药品公司Kite Pharma和Novartis正在争取获得这一疗法的批准,这种疗法涉及基因工程,对患者的免疫系统的T细胞基因改造,并使用它们来对抗他们的癌症。 尽管在一些公司的研究中存在导致患者死亡的毒性问题,但该治疗仍有希望被批准作为治疗白血病和淋巴瘤患者的方法。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1988867, encodeId=c6fb198886e1c, content=<a href='/topic/show?id=502868963bf' target=_blank style='color:#2F92EE;'>#生命科学领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68963, encryptionId=502868963bf, topicName=生命科学领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Thu Aug 10 08:35:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881559, encodeId=522c1881559de, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jul 27 05:35:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439523, encodeId=974b143952326, content=<a href='/topic/show?id=3d52689512b' target=_blank style='color:#2F92EE;'>#生命科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68951, encryptionId=3d52689512b, topicName=生命科学)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Dec 28 06:35:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=166087, encodeId=fefe16608e97, content=很受用,以后临床用得到, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Dec 27 14:20:48 CST 2016, time=2016-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165819, encodeId=ceae165819e2, content=感动的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 26 15:41:55 CST 2016, time=2016-12-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1988867, encodeId=c6fb198886e1c, content=<a href='/topic/show?id=502868963bf' target=_blank style='color:#2F92EE;'>#生命科学领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68963, encryptionId=502868963bf, topicName=生命科学领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Thu Aug 10 08:35:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881559, encodeId=522c1881559de, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jul 27 05:35:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439523, encodeId=974b143952326, content=<a href='/topic/show?id=3d52689512b' target=_blank style='color:#2F92EE;'>#生命科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68951, encryptionId=3d52689512b, topicName=生命科学)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Dec 28 06:35:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=166087, encodeId=fefe16608e97, content=很受用,以后临床用得到, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Dec 27 14:20:48 CST 2016, time=2016-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165819, encodeId=ceae165819e2, content=感动的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 26 15:41:55 CST 2016, time=2016-12-26, status=1, ipAttribution=)]
    2017-07-27 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1988867, encodeId=c6fb198886e1c, content=<a href='/topic/show?id=502868963bf' target=_blank style='color:#2F92EE;'>#生命科学领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68963, encryptionId=502868963bf, topicName=生命科学领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Thu Aug 10 08:35:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881559, encodeId=522c1881559de, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jul 27 05:35:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439523, encodeId=974b143952326, content=<a href='/topic/show?id=3d52689512b' target=_blank style='color:#2F92EE;'>#生命科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68951, encryptionId=3d52689512b, topicName=生命科学)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Dec 28 06:35:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=166087, encodeId=fefe16608e97, content=很受用,以后临床用得到, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Dec 27 14:20:48 CST 2016, time=2016-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165819, encodeId=ceae165819e2, content=感动的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 26 15:41:55 CST 2016, time=2016-12-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1988867, encodeId=c6fb198886e1c, content=<a href='/topic/show?id=502868963bf' target=_blank style='color:#2F92EE;'>#生命科学领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68963, encryptionId=502868963bf, topicName=生命科学领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Thu Aug 10 08:35:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881559, encodeId=522c1881559de, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jul 27 05:35:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439523, encodeId=974b143952326, content=<a href='/topic/show?id=3d52689512b' target=_blank style='color:#2F92EE;'>#生命科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68951, encryptionId=3d52689512b, topicName=生命科学)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Dec 28 06:35:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=166087, encodeId=fefe16608e97, content=很受用,以后临床用得到, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Dec 27 14:20:48 CST 2016, time=2016-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165819, encodeId=ceae165819e2, content=感动的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 26 15:41:55 CST 2016, time=2016-12-26, status=1, ipAttribution=)]
    2016-12-27 虈亣靌

    很受用,以后临床用得到

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1988867, encodeId=c6fb198886e1c, content=<a href='/topic/show?id=502868963bf' target=_blank style='color:#2F92EE;'>#生命科学领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68963, encryptionId=502868963bf, topicName=生命科学领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Thu Aug 10 08:35:00 CST 2017, time=2017-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1881559, encodeId=522c1881559de, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Thu Jul 27 05:35:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1439523, encodeId=974b143952326, content=<a href='/topic/show?id=3d52689512b' target=_blank style='color:#2F92EE;'>#生命科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68951, encryptionId=3d52689512b, topicName=生命科学)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Dec 28 06:35:00 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=166087, encodeId=fefe16608e97, content=很受用,以后临床用得到, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Dec 27 14:20:48 CST 2016, time=2016-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165819, encodeId=ceae165819e2, content=感动的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Mon Dec 26 15:41:55 CST 2016, time=2016-12-26, status=1, ipAttribution=)]
    2016-12-26 thlabcde

    感动的!

    0

相关资讯

Nature:首次!科学家找到了衰老背后的一个新“秘密”

衰老又出新成果啦。发表在《自然》上的一项研究中,科学家们首次发现,衰老与RNA剪接相关。这究竟是怎么一回事呢?

Nature:“长寿药”激烈大战,这名“选手”你不可忽略!

谈及抗衰老、长寿相关的研究,大家可能很容易想到二甲双胍、雷帕霉素等被经常报道的“热门潜力股”。今天,小编要与大家分享一篇发表在Nature Reviews Molecular Cell Biology上(影响因子高达38.602)的综述。在这一综述中,科学家们详细揭秘了抗衰老家族的另一重要成员。它究竟是谁呢?8月24日,来自哈佛医学院的David A. Sinclair教授(通讯作者)和Mic

Nature:剑桥大学科学家让T细胞“活更久”

本月,免疫疗法中的PD-1/PD-L1抗体“家族”收获多个喜讯。首个治疗转移性非小细胞肺癌(NSCLC)的PD-L1抗体(Atezolizumab)获批,PD-1抗体Keytruda正式被批准用于NSCLC一线治疗,这些消息再次证明了癌症免疫疗法的绝对实力。

盘点:9月Nature杂志精选文章一览

【1】Nature:被误诊了30年,基因测序终于确诊了这种病近日,Nature刊登了一篇题为《Diagnosis: A clear answer》的文章,讲述了基因测序如何让一个被误诊30年的女性得到了确诊。在基因测序结果的指导下,她服用了靶向特定突变的药物,病情得到了缓解。经过了30年误诊后,Elizabeth Davis接受了外显子测序,最终疾病得到了确诊,并接受有效的治疗方案。故事的主人

Nature:遗传分析带你揭开睡眠的奥秘

近期,日本筑波大学的研究人员,对携带随机突变的小鼠进行了研究,以分离那些具有睡眠/觉醒异常的小鼠。这种大规模的筛选过程,确定了睡眠表型和突变基因,揭示了两种蛋白质对于调节睡眠需要和维持快速眼动睡眠周期的作用。相关研究结果发表在最近的《Nature》杂志。

Nature Medicine:数年度人物,看“八仙过海”

导读 近日,Nature Medicine也盘点了2016年医药领域的热门人物(六大领域)。其中,包括由技术亿万富翁转型乐善好施的医疗慈善家,为提高药品安全的领军人物,致力于改进医药行业的雄心勃勃者……最慈善的企业家——扎克伯格夫妇&肖恩·帕克Mark Zuckerberg, Priscilla Chan & Sean Parker ,Most charitable statu